Unknown

Dataset Information

Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline.


ABSTRACT:

Background and objective

Experimental studies suggest that the balance between short and long β-amyloid (Aβ) species might modulate the toxic effects of Aβ in Alzheimer disease (AD), but clinical evidence is lacking. We studied whether Aβ38 levels in CSF relate to risk of AD dementia and cognitive decline.

Methods

CSF Aβ38 levels were measured in 656 individuals across 2 clinical cohorts: the Swedish BioFINDER study and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Cox regression models were used to evaluate the association between baseline Aβ38 levels and risk of AD dementia in AD biomarker-positive individuals (AD+; determined by CSF phosphorylated tau [P-tau]/Aβ42 ratio) with subjective cognitive decline (SCD) or mild

SUBMITTER: Cullen N 

PROVIDER: S-EPMC8901176 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature